Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes

被引：0
|
作者：
Emily J. Gallagher
Zara Zelenko
Aviva Tobin-Hess
Ulrich Werner
Norbert Tennagels
Derek LeRoith
机构：
[1] Icahn School of Medicine at Mount Sinai,Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine
[2] Sanofi-Aventis Deutschland GmbH,Diabetes Research & Translational Medicine, Insulin Biology
来源：
Diabetologia | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：758 / 759
页数：1
相关论文
共 50 条
  • [41] Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice
    Hidvegi, Tibor
    Balogh, Zoltan
    Vass, Viktor
    Kovacs, Gabor
    Stella, Peter
    DIABETES THERAPY, 2020, 11 (02) : 467 - 478
  • [42] THE ASSESSMENT OF GLYCEMIC CONTROL IN ROMANIAN TYPE 2 DIABETES PATIENTS TREATED WITH INSULIN GLARGINE AFTER FAILURE OF NON-INSULIN THERAPY IN DAILY CLINICAL PRACTICE
    Guja, Cristian
    Botnariu, Gina
    Cerghizan, Anca
    Dinca, Mihaela
    Popa, Amorin
    Suciu, Gina
    INTERDIAB 2016: DIABETES MELLITUS AS CARDIOVASCULAR DISEASE, 2016, : 255 - 266
  • [43] Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice
    Tibor Hidvégi
    Zoltán Balogh
    Viktor Vass
    Gábor Kovács
    Péter Stella
    Diabetes Therapy, 2020, 11 : 467 - 478
  • [44] Does type 2 diabetes increase the risk of breast cancer? The Nurses' Health Study.
    Michels, KB
    Solomon, CG
    Hu, FB
    Rosner, BA
    Hibert, EN
    Hankinson, SE
    Colditz, GA
    Manson, JE
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (11) : s25 - s25
  • [45] Insulin glargine use and cancer risk among patients with type 2 diabetes mellitus: a real-world study in Shanghai, China
    Jiying Qi
    Ping He
    Huayan Yao
    Wen Sun
    Ping Lu
    Zizheng Zhang
    Bin Cui
    Guang Ning
    International Journal of Diabetes in Developing Countries, 2024, 44 : 137 - 144
  • [46] Insulin glargine use and cancer risk among patients with type 2 diabetes mellitus: a real-world study in Shanghai, China
    Qi, Jiying
    He, Ping
    Yao, Huayan
    Sun, Wen
    Lu, Ping
    Zhang, Zizheng
    Cui, Bin
    Ning, Guang
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (01) : 137 - 144
  • [47] Acceleration of Breast Cancer Development and Progression in a Non-Obese Model of Type 2 Diabetes Is Reversed by Antidiabetic Treatment and Blockade of Insulin and IGF-I Receptors
    Novosyadlyy, Ruslan
    Fierz, Yvonne
    Lann, Danielle
    Vijayakumar, Archana
    Rowzee, Anne
    Lazzarino, Deborah A.
    Pennisi, Patricia A.
    Molinolo, Alfredo A.
    Kurshan, Naamit
    Mejia, Wilson
    Santopietro, Stefania
    Yakar, Shoshana
    Wood, Teresa L.
    Leroith, Derek
    DIABETES, 2009, 58 : A344 - A344
  • [48] High Dietary Fat Intake Exacerbates Insulin Resistance in a Type 2 Diabetes Genetic Mouse Model
    Reilly, Austin
    Yan, Shijun
    Loncharich, Alexa J.
    Ren, Hongxia
    DIABETES, 2020, 69
  • [49] Improvement of hyperglycemia with phloridzin in a type 2 diabetes transgenic mouse model fails to reverse insulin resistance
    Zhao, H
    Yakar, S
    Gavrilova, O
    Sun, H
    Zhang, Y
    Kim, H
    Setser, J
    Leroith, D
    DIABETES, 2004, 53 : A560 - A560
  • [50] Intensification of insulin therapy in patients with type 2 diabetes: a retrospective, non- interventional cohort study of patients treated with insulin glargine or biphasic human insulin in daily clinical practice
    Tentolouris, Nicholas
    Kyriazopoulou, Venetsana
    Makrigiannis, Dimitrios
    Baroutsou, Barbara
    DIABETOLOGY & METABOLIC SYNDROME, 2013, 5
12345